159 related articles for article (PubMed ID: 15717274)
21. Interleukin-10 -1082 gene polymorphism and susceptibility to cervical cancer among Japanese women.
Matsumoto K; Oki A; Satoh T; Okada S; Minaguchi T; Onuki M; Ochi H; Nakao S; Sakurai M; Abe A; Hamada H; Yoshikawa H
Jpn J Clin Oncol; 2010 Nov; 40(11):1113-6. PubMed ID: 20558465
[TBL] [Abstract][Full Text] [Related]
22. [Comparison of high-risk human papillomavirus infection rate and genotype distribution between Han and Mongolian women].
Zhao S; Zhao XL; Hu SY; Wang Y; Remila R; Xu XQ; Duan XZ; Chen F; Zhang X; Zhao FH
Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Nov; 40(11):1439-1444. PubMed ID: 31838818
[No Abstract] [Full Text] [Related]
23. Association of tumor necrosis factor-alpha promoter variants with risk of HPV-associated oral squamous cell carcinoma.
Jin L; Sturgis EM; Zhang Y; Huang Z; Song X; Li C; Wei Q; Li G
Mol Cancer; 2013 Jul; 12():80. PubMed ID: 23870134
[TBL] [Abstract][Full Text] [Related]
24. Polymorphisms and haplotypes of TLR4, TLR9 and CYP1A1 genes possibly interfere with high-risk human papillomavirus infection and cervical cancer susceptibility in Jharkhand, India.
Nath N; Mishra P; Panda AK; Mishra R
Int Immunopharmacol; 2020 Nov; 88():106925. PubMed ID: 32871478
[TBL] [Abstract][Full Text] [Related]
25. FOXP3 immunoregulatory gene variants are independent predictors of human papillomavirus infection and cervical cancer precursor lesions.
Cezar-Dos-Santos F; Ferreira RS; Okuyama NCM; Trugilo KP; Sena MM; Pereira ÉR; Pereira APL; Watanabe MAE; de Oliveira KB
J Cancer Res Clin Oncol; 2019 Aug; 145(8):2013-2025. PubMed ID: 31177386
[TBL] [Abstract][Full Text] [Related]
26. Risk allelic load in Th2 and Th3 cytokines genes as biomarker of susceptibility to HPV-16 positive cervical cancer: a case control study.
Torres-Poveda K; Burguete-García AI; Bahena-Román M; Méndez-Martínez R; Zurita-Díaz MA; López-Estrada G; Delgado-Romero K; Peralta-Zaragoza O; Bermúdez-Morales VH; Cantú D; García-Carrancá A; Madrid-Marina V
BMC Cancer; 2016 May; 16():330. PubMed ID: 27220278
[TBL] [Abstract][Full Text] [Related]
27. Interaction between susceptibility loci in cGAS-STING pathway, MHC gene and HPV infection on the risk of cervical precancerous lesions in Chinese population.
Xiao D; Huang W; Ou M; Guo C; Ye X; Liu Y; Wang M; Zhang B; Zhang N; Huang S; Zang J; Zhou Z; Wen Z; Zeng C; Wu C; Huang C; Wei X; Yang G; Jing C
Oncotarget; 2016 Dec; 7(51):84228-84238. PubMed ID: 27705945
[TBL] [Abstract][Full Text] [Related]
28. Variants in human papillomavirus receptor and associated genes are associated with type-specific HPV infection and lesion progression of the cervix.
Zou J; Cao Z; Zhang J; Chen T; Yang S; Huang Y; Hong D; Li Y; Chen X; Wang X; Cheng X; Lu W; Xie X
Oncotarget; 2016 Jun; 7(26):40135-40147. PubMed ID: 27223085
[TBL] [Abstract][Full Text] [Related]
29. Case-control study of HLA-G promoter methylation status, HPV infection and cervical neoplasia in Curitiba, Brazil: a pilot analysis.
Gillio-Tos A; Bicalho Mda G; Fiano V; Grasso C; Tarallo V; De Marco L; Trevisan M; Xavier M; Slowik R; Carvalho NS; Maestri CA; Lacerda HM; Zugna D; Richiardi L; Merletti F
BMC Cancer; 2012 Dec; 12():618. PubMed ID: 23265140
[TBL] [Abstract][Full Text] [Related]
30. HLA-DP is the cervical cancer susceptibility loci among women infected by high-risk human papillomavirus: potential implication for triage of human papillomavirus-positive women.
Jia M; Han J; Hang D; Jiang J; Wang M; Wei B; Dai J; Zhang K; Guo L; Qi J; Ma H; Shi J; Ren J; Hu Z; Dai M; Li N
Tumour Biol; 2016 Jun; 37(6):8019-25. PubMed ID: 26711785
[TBL] [Abstract][Full Text] [Related]
31. Human leukocyte antigen-DRB1*1501 and DQB1*0602 alleles are cervical cancer protective factors among Uighur and Han people in Xinjiang, China.
Hu JM; Sun Q; Li L; Liu CX; Chen YZ; Zou H; Pang LJ; Zhao J; Yang L; Cao YW; Cui XB; Qi Y; Liang WH; Zhang WJ; Li F
Int J Clin Exp Pathol; 2014; 7(9):6165-71. PubMed ID: 25337265
[TBL] [Abstract][Full Text] [Related]
32. Comparison of human leukocyte antigen DR-DQ disease associations found with cervical dysplasia and invasive cervical carcinoma.
Apple RJ; Becker TM; Wheeler CM; Erlich HA
J Natl Cancer Inst; 1995 Mar; 87(6):427-36. PubMed ID: 7861462
[TBL] [Abstract][Full Text] [Related]
33. Reduced rate of human papillomavirus infection and genetic overtransmission of TP53 72C polymorphic variant lower cervical cancer incidence.
Alsbeih GA; Al-Harbi NM; Bin Judia SS; Khoja HA; Shoukri MM; Tulbah AM
Cancer; 2017 Jul; 123(13):2459-2466. PubMed ID: 28393355
[TBL] [Abstract][Full Text] [Related]
34. Association of tumor necrosis factor a-2 and a-8 microsatellite alleles with human papillomavirus and squamous intraepithelial lesions among women in Brazil.
Simões RT; Gonçalves MA; Donadi EA; Simões AL; Bettini JS; Duarte G; Quintana SM; Carvalho MW; Soares EG
J Clin Microbiol; 2005 Aug; 43(8):3932-7. PubMed ID: 16081933
[TBL] [Abstract][Full Text] [Related]
35. TNF-α promoter single nucleotide polymorphisms and haplotypes associate with susceptibility of immune thrombocytopenia in Chinese adults.
Wang N; Li GN; Wang XB; Liang T; Hu L
Hum Immunol; 2014 Sep; 75(9):980-5. PubMed ID: 25158149
[TBL] [Abstract][Full Text] [Related]
36. Human papillomavirus infection and P53 codon 72 genotypes in a Hispanic population at high-risk for cervical cancer.
Haws AL; Woeber S; Gomez M; Garza N; Gomez Y; Rady P; He Q; Zhang L; Grady JJ; McCormick JB; Fisher-Hoch SP; Tyring SK
J Med Virol; 2005 Oct; 77(2):265-72. PubMed ID: 16121365
[TBL] [Abstract][Full Text] [Related]
37. MBL2 gene polymorphisms are correlated with high-risk human papillomavirus infection but not with human papillomavirus-related cervical cancer.
Segat L; Crovella S; Comar M; Milanese M; Zanotta N; Fabris A; Trevisiol C; Rossi T; De Seta F; Campello C
Hum Immunol; 2009 Jun; 70(6):436-9. PubMed ID: 19275921
[TBL] [Abstract][Full Text] [Related]
38. Development of a novel microarray methodology for the study of SNPs in the promoter region of the TNF-alpha gene: their association with obstructive pulmonary disease in Greek patients.
Papatheodorou A; Latsi P; Vrettou C; Dimakou A; Chroneou A; Makrythanasis P; Kaliakatsos M; Orfanidou D; Roussos C; Kanavakis E; Tzetis M
Clin Biochem; 2007 Aug; 40(12):843-50. PubMed ID: 17509552
[TBL] [Abstract][Full Text] [Related]
39. Polymorphism of MMP1 and MMP3 promoter regions and HR-HPV infection in women from Burkina Faso and Côte d'Ivoire.
Bado P; Djigma Wendkuuni F; Zohoncon Théodora M; Obiri-Yeboah D; Traoré Esther Mah A; Ouattara Abdoul K; Ouedraogo Teega-Wendé C; Bello Shoukrat Ohuwa T; Setor Marius A; Traore Ina Marie A; Horo A; Kouakou Kouame P; Yonli Albert T; Ouedraogo C; Simpore J
Biomol Concepts; 2020 May; 11(1):116-124. PubMed ID: 32417757
[TBL] [Abstract][Full Text] [Related]
40. Tumor Necrosis Factor Alpha (-238 / -308) and TNFRII-VNTR (-322) Polymorphisms as Genetic Biomarkers of Susceptibility to Develop Cervical Cancer Among Tunisians.
Zidi S; Stayoussef M; Zouidi F; Benali S; Gazouani E; Mezlini A; Yacoubi-Loueslati B
Pathol Oncol Res; 2015 Apr; 21(2):339-45. PubMed ID: 25113639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
